Advertisement
Australia markets closed
  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     
  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     
  • AUD/USD

    0.6582
    +0.0011 (+0.17%)
     
  • OIL

    79.24
    +0.29 (+0.37%)
     
  • GOLD

    2,308.30
    -1.30 (-0.06%)
     
  • Bitcoin AUD

    90,182.64
    +2,223.35 (+2.53%)
     
  • CMC Crypto 200

    1,284.25
    +7.27 (+0.57%)
     
  • AUD/EUR

    0.6127
    +0.0007 (+0.12%)
     
  • AUD/NZD

    1.1006
    -0.0003 (-0.02%)
     
  • NZX 50

    11,938.08
    +64.04 (+0.54%)
     
  • NASDAQ

    17,541.54
    +222.99 (+1.29%)
     
  • FTSE

    8,198.42
    +26.27 (+0.32%)
     
  • Dow Jones

    38,225.66
    +322.37 (+0.85%)
     
  • DAX

    17,962.65
    +66.15 (+0.37%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

Ultimovacs ASA – Annual General Meeting held on April 18, 2024

Ultimovacs ASA
Ultimovacs ASA

Oslo, April 18, 2023: Ultimovacs ASA held its annual general meeting today April 18, 2024. All the matters on the agenda were approved.

The following board members were re-elected for a period of one year, and the Board of Directors will consist of the following persons:

  • Jónas Einarsson, Chair of the Board

  • Henrik Schüssler, board member

  • Kari Grønås, board member

  • Ketil Fjerdingen, deputy board member

The Nomination Committee will consist of the following persons until the Annual General Meeting in 2025:

  • Ole Kristian Hjelstuen, Chair of the committee

  • Hans Peter Bøhn, committee member

The minutes from the meeting are enclosed and available at the company’s website.

ADVERTISEMENT

For further information, please see www.ultimovacs.com or contact:

Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASA

Email: je@radforsk.no

Phone: +47 480 96 355

Carlos de Sousa, CEO

Email: carlos.desousa@ultimovacs.com

Phone: +47 908 92507

        

Anne Worsøe, Head of IR & Communication

Email: anne.worsoe@ultimovacs.com

Phone: +47 906 86815


Attachment